FILTER
Refine your search with the following facets to narrow down your results.
- Novartis 13
- rheumatoid arthritis 12
- drug development 10
- inflammation 10
- license agreements 10
- human antibodies 9
- oncology 8
- biopharmaceuticals 7
- patents 7
- Germany 5
- biotechnology 5
- cancer 5
- gold 5
- infectious diseases 5
- inflammatory diseases 5
- monoclonal antibodies 5
- proteins 5
- Galapagos 4
- diseases 4
- immunology 4
- medicine 4
- Boehringer Ingelheim 3
- Daiichi Sankyo 3
- Schering 3
- USA 3
- diagnostics 3
- inhibitors 3
- multiple myeloma 3
- services 3
- validation 3
- Antikörper 2
- Astellas Pharma 2
- Formation 2
- GPC Biotech 2
- Japan 2
- Schering Plough 2
- Wacker Chemie 2
- angiogenesis 2
- autoimmune diseases 2
- bases 2
- biology 2
- cell lines 2
- collaborations 2
- education 2
- evolution 2
- immunogenicity 2
- multiple sclerosis 2
- osteoarthritis 2
- osteoporosis 2
- personnel changes 2
- phase I studies 2
- platinum 2
- recombinant proteins 2
- reductions 2
- technology transfer 2
- tumors 2
- Abbott 1
- Arndt Schottelius 1
- Bayer HealthCare 1
- Bayer Schering 1
- Binder 1
- Bristol-Myers Squibb 1
- Brustkrebs 1
- Denmark 1
- Eli Lilly 1
- Expression 1
- G protein-coupled receptors 1
- Geneart 1
- Genentech 1
- Genmab 1
- Gerald Möller 1
- Hamilton 1
- Investment 1
- Life Science 1
- Lilly 1
- MSD 1
- Malte Peters 1
- MediGene 1
- Merck 1
- Netherlands 1
- Novo Nordisk 1
- Novozymes 1
- Pfizer 1
- Qiagen 1
- Salmonella 1
- Sigma-Aldrich 1
- Staphylococcus aureus 1
- Switzerland 1
- T cells 1
- United Kingdom 1
- acute lymphoblastic leukemia 1
- adhesion 1
- amino acids 1
- anti-infectives 1
- antibody fragments 1
- MorphoSys AG 107
- Novartis International AG 7
- Galapagos NV 4
- Boehringer Ingelheim Pharma GmbH & Co. KG 3
- Centocor, Inc. 3
- Daiichi Sankyo Company, Limited 3
- OncoMed Pharmaceuticals Inc 3
- U.S. Patent & Trademark Office (USPTO) 3
- University of Melbourne 3
- Astellas Pharma Inc. 2
- Bundesministerium für Bildung und Forschung (BMBF) 2
- Centocor Ortho Biotech Inc. 2
- GPC Biotech AG 2
- Merck & Co., Inc. 2
- Pfizer Inc. 2
- Schering-Plough Corporation 2
- Shionogi & Co., Ltd. 2
- Sloning BioTechnology GmbH 2
- Wacker Biotech GmbH 2
- Wacker Chemie AG 2
- Xencor, Inc. 2
- Absynth Biologics Ltd 1
- Andrew Lloyd & Associates 1
- Bayer Healthcare AG 1
- Bayer Schering Pharma AG 1
- Biogenesis Ltd. 1
- Boehringer Ingelheim Austria GmbH 1
- Bristol-Myers Squibb Co. 1
- ContraFect Corporation (CFRX) 1
- DAIICHI SANKYO EUROPE GmbH 1
- Dana-Farber Cancer Institute 1
- Eli Lilly and Company 1
- G7 Therapeutics AG 1
- GENEART AG 1
- Genmab A/S 1
- Heptares Therapeutics Ltd 1
- Hokkaido University 1
- IBA Lifesciences GmbH 1
- ImmunoGen, Inc. 1
- Janssen Biotech, Inc. 1
- Lanthio Pharma 1
- Medical Research Council (MRC) 1
- MilliporeSigma 1
- Novartis Institutes for BioMedical Research (NIBR) 1
- Novoplant GmbH 1
- Novozymes A/S 1
- Paul-Ehrlich-Institut (PEI) 1
- Proteros Biostructures GmbH 1
- SPINREACT, S.A. 1
- University College London (UCL) 1
- Vivoryon Therapeutics AG 1
107 Current news of MorphoSys
FILTERS
Refine your search with the following facets to narrow down your results.
- Novartis 13
- rheumatoid arthritis 12
- drug development 10
- inflammation 10
- license agreements 10
- human antibodies 9
- oncology 8
- biopharmaceuticals 7
- patents 7
- Germany 5
- biotechnology 5
- cancer 5
- gold 5
- infectious diseases 5
- inflammatory diseases 5
- monoclonal antibodies 5
- proteins 5
- Galapagos 4
- diseases 4
- immunology 4
- medicine 4
- Boehringer Ingelheim 3
- Daiichi Sankyo 3
- Schering 3
- USA 3
- diagnostics 3
- inhibitors 3
- multiple myeloma 3
- services 3
- validation 3
- Antikörper 2
- Astellas Pharma 2
- Formation 2
- GPC Biotech 2
- Japan 2
- Schering Plough 2
- Wacker Chemie 2
- angiogenesis 2
- autoimmune diseases 2
- bases 2
- biology 2
- cell lines 2
- collaborations 2
- education 2
- evolution 2
- immunogenicity 2
- multiple sclerosis 2
- osteoarthritis 2
- osteoporosis 2
- personnel changes 2
- phase I studies 2
- platinum 2
- recombinant proteins 2
- reductions 2
- technology transfer 2
- tumors 2
- Abbott 1
- Arndt Schottelius 1
- Bayer HealthCare 1
- Bayer Schering 1
- Binder 1
- Bristol-Myers Squibb 1
- Brustkrebs 1
- Denmark 1
- Eli Lilly 1
- Expression 1
- G protein-coupled receptors 1
- Geneart 1
- Genentech 1
- Genmab 1
- Gerald Möller 1
- Hamilton 1
- Investment 1
- Life Science 1
- Lilly 1
- MSD 1
- Malte Peters 1
- MediGene 1
- Merck 1
- Netherlands 1
- Novo Nordisk 1
- Novozymes 1
- Pfizer 1
- Qiagen 1
- Salmonella 1
- Sigma-Aldrich 1
- Staphylococcus aureus 1
- Switzerland 1
- T cells 1
- United Kingdom 1
- acute lymphoblastic leukemia 1
- adhesion 1
- amino acids 1
- anti-infectives 1
- antibody fragments 1
- MorphoSys AG 107
- Novartis International AG 7
- Galapagos NV 4
- Boehringer Ingelheim Pharma GmbH & Co. KG 3
- Centocor, Inc. 3
- Daiichi Sankyo Company, Limited 3
- OncoMed Pharmaceuticals Inc 3
- U.S. Patent & Trademark Office (USPTO) 3
- University of Melbourne 3
- Astellas Pharma Inc. 2
- Bundesministerium für Bildung und Forschung (BMBF) 2
- Centocor Ortho Biotech Inc. 2
- GPC Biotech AG 2
- Merck & Co., Inc. 2
- Pfizer Inc. 2
- Schering-Plough Corporation 2
- Shionogi & Co., Ltd. 2
- Sloning BioTechnology GmbH 2
- Wacker Biotech GmbH 2
- Wacker Chemie AG 2
- Xencor, Inc. 2
- Absynth Biologics Ltd 1
- Andrew Lloyd & Associates 1
- Bayer Healthcare AG 1
- Bayer Schering Pharma AG 1
- Biogenesis Ltd. 1
- Boehringer Ingelheim Austria GmbH 1
- Bristol-Myers Squibb Co. 1
- ContraFect Corporation (CFRX) 1
- DAIICHI SANKYO EUROPE GmbH 1
- Dana-Farber Cancer Institute 1
- Eli Lilly and Company 1
- G7 Therapeutics AG 1
- GENEART AG 1
- Genmab A/S 1
- Heptares Therapeutics Ltd 1
- Hokkaido University 1
- IBA Lifesciences GmbH 1
- ImmunoGen, Inc. 1
- Janssen Biotech, Inc. 1
- Lanthio Pharma 1
- Medical Research Council (MRC) 1
- MilliporeSigma 1
- Novartis Institutes for BioMedical Research (NIBR) 1
- Novoplant GmbH 1
- Novozymes A/S 1
- Paul-Ehrlich-Institut (PEI) 1
- Proteros Biostructures GmbH 1
- SPINREACT, S.A. 1
- University College London (UCL) 1
- Vivoryon Therapeutics AG 1